Apellis Pharmaceuticals Inc - Bathi resik saben siji saham sajrone rolas wulan pungkasan APLS

The annual EPS TTM growth rate on GURU.Markets reflects profit dynamics based on the diversification of Apellis Pharmaceuticals (APLS) therapeutic platforms. A monopoly position in retinal treatment allows the company to implement premium pricing. A stable staff of scientists and the active hiring of sales managers strengthen its commercial potential. The value of 158.00 determines this parameter level, helping investors assess the efficiency of capital allocation.

APLS Apellis Pharmaceuticals: Bathi resik saben saham (EPS TTM) ing interval 11.02.2024 - 30.05.2026

Apellis Pharmaceuticals Inc - rincian analitis lan metrik utama (APLS)

- rega lan prakiraan konsensus rega:

Rega bursa apellis.com|APLS - Prakiraan konsensus analis

- rincian nilai pasar emiten:

Nilai pasar Apellis Pharmaceuticals, Inc.|APLS - Nilai Total Perusahaan

- rincian nilai buku perusahaan:

Aset Bersih saben Saham Apellis Pharmaceuticals|APLS - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku apellis.com|APLS - Aset Agregat Perusahaan

- data utang lan likuiditas:

Utang Agregat marang Ekuitas Apellis Pharmaceuticals|APLS - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Apellis Corp|APLS - Utang perusahaan|Rasio utang marang kapitalisasi buku Apellis Pharmaceuticals, Inc.|APLS - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Apellis Pharmaceuticals|Koefisien jangkoan perantara apellis.com

- data bathi bisnis lan rasio investasi:

APLS - Bathi resik perusahaan|Prakiraan bathi perusahaan Apellis Pharmaceuticals|APLS - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi Apellis Pharmaceuticals, Inc.|APLS - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan Apellis Pharmaceuticals, Inc.|APLS - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku Apellis Pharmaceuticals|APLS - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan apellis.com|APLS - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Apellis Pharmaceuticals

Analisis wiwitan perusahaan:apellis.com - APLS

To isolate fundamental stability from market noise, capital requires an analysis of the rolling annual earnings per share, which measures the rate of change in net income over the last 12 months relative to the previous year. The trend of the 12-month EPS growth reflects the efficiency of business scaling, which for Apellis Pharmaceuticals (APLS) is supported by the implementation of robotic bio-screening to accelerate the development of targeted drugs.

Analisis pesaing